Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | BIPSX Insights | BIPSX Score | BIPSX Performance | BIPSX News | BIPSX Allocation | BIPSX Holdings Change

ProFunds Biotechnology UltraSector Svc (BIPSX) Fund Ranking and Research

Ranking, Research and Recommendation of ProFunds Biotechnology UltraSector Svc (BIPSX) Fund

    Last Trade: $44.58 on 4/21/2017, Change: -0.48 (-1.07%)

 

Graph of ProFunds Biotechnology UltraSector Svc Fund (BIPSX) ManagerFund Manager - Michael Neches

Fund Manager Information

Fund Manager Tenure: 3.6 years
Similar Funds: BIPIX 
Fund Family: ProFunds
Fund Category: Trading--Leveraged Equity
Fund Performance: May 30, 2016
Fundmojo Fund Grade: C (Score: 0.52)     (What does this score mean?)

 

Graph of ProFunds Biotechnology UltraSector Svc Fund (BIPSX) ProfileProFunds Biotechnology UltraSector Svc Fund (BIPSX) Profile

Fund Profile and Description

ProFunds Biotechnology UltraSector Svc Fund seeks daily investment results, before fees and expenses, that correspond to one and one-half times (150%) the daily performance of the Index. ProFunds Biotechnology UltraSector Svc Fund invests in equity securities and derivatives that ProFund Advisors believes, in combination, should have similar daily return characteristics as one and one-half times (150%) the daily return of the Index. Assets of the fund not invested in equity securities or derivatives will typically be held in money market instruments. It is non-diversified.

 

ProFunds Biotechnology UltraSector Svc (BIPSX) Fund Strength What we like about ProFunds Biotechnology UltraSector Svc (BIPSX) Fund

Data for ProFunds Biotechnology UltraSector Svc Fund (BIPSX) as of May 30, 2016

  • ProFunds Biotechnology UltraSector Svc Fund (BIPSX) management has been with ProFunds Biotechnology UltraSector Svc Fund for 3.6 years
  • ProFunds Biotechnology UltraSector Svc Fund (BIPSX) has good mid-term performance (3-year return 18.40% vs 10.54% Trading--Leveraged Equity category median performance)
  • ProFunds Biotechnology UltraSector Svc Fund (BIPSX) has good Long-term performance (5-year return 30.54% vs 11.60% Trading--Leveraged Equity category median performance)
  • ProFunds Biotechnology UltraSector Svc Fund (BIPSX) ratio of up-years vs down years is greater than 2
  • ProFunds Biotechnology UltraSector Svc Fund (BIPSX) has an annual stock turnover rate of 11.00% vs Trading--Leveraged Equity average of 241.85%. It is good that ProFunds Biotechnology UltraSector Svc management does not trade extensively for its return.

ProFunds Biotechnology UltraSector Svc Fund (BIPSX) Weakness What we are cautious about ProFunds Biotechnology UltraSector Svc (BIPSX) Fund

Data for ProFunds Biotechnology UltraSector Svc Fund (BIPSX) as of May 30, 2016

  • ProFunds Biotechnology UltraSector Svc Fund (BIPSX) has a less-than-ideal short-term performance (1-year return -26.61% vs -4.19% Trading--Leveraged Equity category median performance)
  • ProFunds Biotechnology UltraSector Svc Fund (BIPSX) has a Morningstar rating of 3 and below
  • ProFunds Biotechnology UltraSector Svc Fund (BIPSX) is less safe compared to its Trading--Leveraged Equity peers
  • ProFunds Biotechnology UltraSector Svc Fund (BIPSX) has a higher expense ratio of 2.52% than its Trading--Leveraged Equity average of 1.98%
  • Even though ProFunds Biotechnology UltraSector Svc Fund carries no load, it does have a 1.00% of 12b1 promotion, distributions, marketing expenses
See ProFunds Biotechnology UltraSector Svc Fund (BIPSX) performance details as of May 30, 2016

 

What do you think?

 

Compare ProFunds Biotechnology UltraSector Svc Fund (BIPSX)Compare with other top Trading--Leveraged Equity category mutual funds

Aadditional top Trading--Leveraged Equity mutual funds for your consideration

FundYear to Date1 Year3 year5 year
ProFunds Biotechnology UltraSector Svc-16.99-26.6118.4030.54
Direxion Mthly NASDAQ-100 Bull 2X Inv (DXQLX)-4.14-2.5729.7727.11Compare

See top fund managers for Trading--Leveraged Equity Category Funds

 

Compare ProFunds Biotechnology UltraSector Svc Fund (BIPSX)Compare with Trading--Leveraged Equity category ETFs

Some Trading--Leveraged Equity ETFs for your consideration

ETFYear to DateOne YearThree Year
Direxion Daily Real Estate Bull 3X ETF (DRN)13.32%19.52%21.10%
ProShares Ultra Real Estate (URE)9.51%13.61%14.57%
ProShares Ultra Consumer Goods (UGE)5.96%11.59%20.27%
ProShares Ultra Consumer Services (UCC)000
ProShares Ultra Dow30 (DDM)000

 

Graph of ProFunds Biotechnology UltraSector Svc Fund (BIPSX) Net Asset TrackingProFunds Biotechnology UltraSector Svc (BIPSX) Fund Net Asset

Track net asset change of ProFunds Biotechnology UltraSector Svc fund (BIPSX)

DateNet Asset
05/2016$434.82M
03/2016$410.81M
02/2016$448.78M
More historic net asset information on ProFunds Biotechnology UltraSector Svc Fund (BIPSX)

  

Graph of ProFunds Biotechnology UltraSector Svc Fund (BIPSX) Portfolio TrackingProFunds Biotechnology UltraSector Svc (BIPSX) Fund Portfolio Allocation

Track portfolio allocation change of ProFunds Biotechnology UltraSector Svc fund (BIPSX)

DateCashStockBondOther
01/201628.9%71.08%0%0%
10/201523.02%74.1%0%2.88%
07/201534.15%65.85%0%0%
Click here to see more historic asset allocation information on ProFunds Biotechnology UltraSector Svc Fund (BIPSX)

 

graph of ProFunds Biotechnology UltraSector Svc Fund (BIPSX) Top 10 Position TrackingTop 10 Holdings in ProFunds Biotechnology UltraSector Svc (BIPSX) Fund

Discover what ProFunds Biotechnology UltraSector Svc Fund (BIPSX) manager is buying

Jan 30, 2016
Gilead Sciences, Inc. [12.26%]
Amgen Inc. [11.8%]
AbbVie Inc. Common Stock [9.19%]
Celgene Corporation [8.07%]
Biogen Inc. [6.24%]
Alexion Pharmaceuticals, Inc. [3.37%]
Regeneron Pharmaceuticals, Inc. [3.34%]
Illumina, Inc. [2.37%]
Vertex Pharmaceuticals Incorpor [2.28%]
Baxalta Incorporated Common Sto [2.22%]

Oct 30, 2015
Gilead Sciences, Inc. [14.09%]
Amgen Inc. [10.65%]
AbbVie Inc. Common Stock [8.75%]
Celgene Corporation [8.61%]
Biogen Inc. [5.75%]
Regeneron Pharmaceuticals, Inc. [3.83%]
Alexion Pharmaceuticals, Inc. [3.53%]
Vertex Pharmaceuticals Incorpor [2.71%]
Illumina, Inc. [1.84%]
Incyte Corporation [1.71%]

Jul 30, 2015
Gilead Sciences, Inc. [12.8%]
Amgen Inc. [9.92%]
AbbVie Inc. Common Stock [8.9%]
Celgene Corporation [7.69%]
Biogen Inc. [5.54%]
Alexion Pharmaceuticals, Inc. [3.27%]
Regeneron Pharmaceuticals, Inc. [3.09%]
Vertex Pharmaceuticals Incorpor [2.43%]
Illumina, Inc. [2.34%]
BioMarin Pharmaceutical Inc. [1.73%]
Click here for Stock Holding Change Map in ProFunds Biotechnology UltraSector Svc Fund (BIPSX)

  

Latest News on ProFunds Biotechnology UltraSector Svc (BIPSX) Fund

See what is happening with ProFunds Biotechnology UltraSector Svc Fund (BIPSX)

    No recent news

 

ProFunds Biotechnology UltraSector Svc Fund (BIPSX) Related ResourcesSee more information on ProFunds Biotechnology UltraSector Svc (BIPSX) Fund

Popular pages on ProFunds Biotechnology UltraSector Svc (BIPSX) Fund

  

Fund Mojo Newsletter

Fund Mojo on Facebook Follow FundMojo on Twitter Fund Update